Literature DB >> 26265498

The Impact of Age on the Efficacy of 13-valent Pneumococcal Conjugate Vaccine in Elderly.

Cornelis H van Werkhoven1, Susanne M Huijts2, Marieke Bolkenbaas1, Diederick E Grobbee1, Marc J M Bonten3.   

Abstract

In a post hoc analysis of the Community-Acquired Pneumonia (CAP) immunization Trial in Adults the model-predicted 13-valent pneumococcal conjugate vaccine efficacy for preventing vaccine-type specific CAP and Invasive Pneumococcal Disease declined from 65% to 40% for subjects being 65 and 75 year olds at the time of vaccination, respectively.
© The Author 2015. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  community-acquired pneumonia; immunosenescence; invasive pneumococcal disease; pneumococcal conjugate vaccine; vaccine efficacy

Mesh：

Substances：

Year:  2015        PMID： 26265498     DOI： 10.1093/cid/civ686

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  25 in total

1.  Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant.

Authors:  Daniel M Musher; Maria B Rodriguez-Barradas
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

2.  What do we know about the cost-effectiveness of pneumococcal conjugate vaccination in older adults?

Authors:  A T Newall
Journal:  Hum Vaccin Immunother       Date:  2016-07-11       Impact factor: 3.452

3.  Poor Correlation between Pneumococcal IgG and IgM Titers and Opsonophagocytic Activity in Vaccinated Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia.

Authors:  Johanna Karlsson; Lucy Roalfe; Harriet Hogevik; Marta Zancolli; Björn Andréasson; David Goldblatt; Christine Wennerås
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

4.  Cost Effectiveness of Elderly Pneumococcal Vaccination in Presence of Higher-Valent Pneumococcal Conjugate Childhood Vaccination: Systematic Literature Review with Focus on Methods and Assumptions.

Authors:  Marina Treskova; Stefan M Scholz; Alexander Kuhlmann
Journal:  Pharmacoeconomics       Date:  2019-09       Impact factor: 4.981

Review 5.  Aging of the immune system: Focus on inflammation and vaccination.

Authors:  Marcello Pinti; Victor Appay; Judith Campisi; Daniela Frasca; Tamas Fülöp; Delphine Sauce; Anis Larbi; Birgit Weinberger; Andrea Cossarizza
Journal:  Eur J Immunol       Date:  2016-10       Impact factor: 5.532

6.  Correlation of the ratio of IgM/IgG concentration to days after symptom onset (IgM/T or IgG/T) with disease severity and outcome in non-critical COVID-19 patients.

Authors:  Yan Rong; Fei Wang; Xiaoli Li; Xinhua Liang; Yang Zhou; Dandan Zhang; Jing Liu; Huadong Zeng; Jing Wang; Yi Shi
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 7.  Pneumococcal Capsular Polysaccharide Immunity in the Elderly.

Authors:  Hugh Adler; Daniela M Ferreira; Stephen B Gordon; Jamie Rylance
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

8.  Cost-effectiveness of implementing 13-valent pneumococcal conjugate vaccine for U.S. adults aged 19 years and older with underlying conditions.

Authors:  Miwako Kobayashi; Charles Stoecker; Wei Xing; Bo-Hyun Cho; Tamara Pilishvili
Journal:  Hum Vaccin Immunother       Date:  2021-01-26       Impact factor: 3.452

Review 9.  Pneumonia and Invasive Pneumococcal Diseases: The Role of Pneumococcal Conjugate Vaccine in the Era of Multi-Drug Resistance.

Authors:  Chiara Scelfo; Francesco Menzella; Matteo Fontana; Giulia Ghidoni; Carla Galeone; Nicola Cosimo Facciolongo
Journal:  Vaccines (Basel)       Date:  2021-04-22

10.  SARS-CoV-2 testing and sequencing for international arrivals reveals significant cross border transmission of high risk variants into the United Kingdom.

Authors:  Gareth H Williams; Alexander Llewelyn; Ruben Brandao; Kaiya Chowdhary; Keeda-Marie Hardisty; Marco Loddo
Journal:  EClinicalMedicine       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.